Action Accuray - ARAY

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

2,11

Prix Achat

2,11

Prix Vente

2,19

Volume échangé

765 052

2,07 Fourchette du Jour 2,20

1,40 Plage de 52 semaines 2,95

Cap du marché

216,972M

Clôture Veille

2,16

Ouverture

2,20

Dernière Transaction

2.11

Dernière heure de transaction

Volume financier

US$ 1 629 857

VWAP

2,1304

Volume moyen (3 m)

744 038

Actions en circulation

102 830 522

Rendement du Dividende

Ratio Cours sur Bénéfices

-13,96

Bénéfice par action (BPA)

-0,15

Chiffre d'affairess

446,55M

Bénéfice net

-15,55M

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full ... Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. Show more

Secteur

Surgical,med Instr,apparatus

Industrie

Surgical,med Instr,apparatus

Site Web

www.accuray.com

Siège social

Wilmington, Delaware, USA

Fondé

Accuray Incorporated est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker ARAY. Le dernier cours de clôture d'Accuray était de US$2,16. Au cours de la dernière année, les actions de Accuray ont été négociées dans une fourchette de prix de US$ 1,40 à US$ 2,95.

Accuray compte actuellement 102 830 522 actions en circulation. La capitalisation boursière d'Accuray est de US$222,11 million. Accuray a un ratio cours/bénéfice (ratio PE) de -13.96.

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance PR Newswire MADISON...

Form 8-K - Current report

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.19	-8.26086956522	2.3	2.33	2.11	749119	2.21039776	CS
4	-0.12	-5.38116591928	2.23	2.95	2.11	884921	2.37346035	CS
12	0.19	9.89583333333	1.92	2.95	1.75	744038	2.19180956	CS
26	-0.21	-9.05172413793	2.32	2.95	1.67	689365	2.05827265	CS
52	-0.59	-21.8518518519	2.7	2.95	1.4	708194	2.0268124	CS
156	-1.49	-41.3888888889	3.6	4.299	1.4	617443	2.46702248	CS
260	-1.27	-37.573964497	3.38	6.015	1.33	696701	3.19273767	CS

ARAY - Frequently Asked Questions (FAQ)

What is the current Accuray share price?

The current share price of Accuray is US$ 2,11

How many Accuray shares are in issue?

Accuray has 102 830 522 shares in issue

What is the market cap of Accuray?

The market capitalisation of Accuray is USD 222,11M

What is the 1 year trading range for Accuray share price?

Accuray has traded in the range of US$ 1,40 to US$ 2,95 during the past year

What is the PE ratio of Accuray?

The price to earnings ratio of Accuray is -13,96

What is the cash to sales ratio of Accuray?

The cash to sales ratio of Accuray is 0,49

What is the reporting currency for Accuray?

Accuray reports financial results in USD

What is the latest annual turnover for Accuray?

The latest annual turnover of Accuray is USD 446,55M

What is the latest annual profit for Accuray?

The latest annual profit of Accuray is USD -15,55M

What is the registered address of Accuray?

The registered address for Accuray is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Accuray website address?

The website address for Accuray is www.accuray.com

Which industry sector does Accuray operate in?

Accuray operates in the SURGICAL,MED INSTR,APPARATUS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MLGOMicroAlgo Inc	US$ 6,3767 (454,50%)	531,52M
BOXLBoxlight Corporation	US$ 3,1099 (51,70%)	1,84M
GDEVGDEV Inc	US$ 20,90 (46,56%)	264,43k
IVVDInvivyd Inc	US$ 1,7501 (44,64%)	37,74M
UPCUniverse Pharmaceuticals Inc	US$ 0,2003 (40,56%)	420,17M
DOYUDouYu International Holdings Ltd	US$ 7,19 (-55,31%)	1,28M
MNDRMobile health Network Solutions	US$ 0,5048 (-46,29%)	18,61M
BLUEbluebird bio Inc	US$ 4,09 (-41,90%)	5,44M
FLDFold Holdings Inc	US$ 6,95 (-37,39%)	488,54k
GCLGCL Global Holdings Ltd	US$ 3,83 (-31,48%)	635,26k
MLGOMicroAlgo Inc	US$ 6,3767 (454,50%)	531,54M
UPCUniverse Pharmaceuticals Inc	US$ 0,2003 (40,56%)	420,21M
ADTXAditxt Inc	US$ 0,0922 (-22,39%)	278,25M
NVDANVIDIA Corporation	US$ 134,43 (-4,05%)	228,14M
HOLOMicroCloud Hologram Inc	US$ 1,565 (31,51%)	190,81M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Accuray Incorporated (ARAY) Cours

Accuray Incorporated (ARAY)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Accuray Incorporated

ARAY Dernières nouvelles

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Form 8-K - Current report

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Form 8-K - Current report

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Leonel Peralta to Join Accuray as Chief Operations Officer

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

ARAY - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités